XML 25 R13.htm IDEA: XBRL DOCUMENT
v3.25.1

Financial Instruments and Fair Value Measurements | 6 Months Ended
--- | ---
Mar. 29, 2025
Fair Value Disclosures [Abstract] |
Financial Instruments and Fair Value Measurements | Financial Instruments and Fair Value Measurements In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors. The Company may use derivative financial instruments to help manage market risk and reduce the exposure to fluctuations in foreign currencies. These financial instruments are not used for trading or other speculative purposes. Cross-Currency Swaps The Company is party to certain cross-currency swaps to hedge a portion of our foreign currency risk. During the quarter ended March 29, 2025, the Company received net proceeds of $22 million related to the settlement of existing cross-currency rate swaps, with the offset being recorded in Accumulated other comprehensive loss. Following the settlement, the Company entered into a €250 million and a €425 million cross-currency swap, maturing November 2027 and November 2029 respectively. The swaps are designated as a hedge of the Company’s foreign currency investment in foreign subsidiaries. The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized. Balances on a gross basis are as follows:
Derivative Instruments | Hedge Designation | Balance Sheet Location |  | March 29, 2025 |  | September 28, 2024
Cross-currency swaps | Designated | Other long-term liabilities |  | $ | (38) |  |  | $ | — |
The effect of the Company’s derivative instruments on the Consolidated and Combined Statements of Operations is as follows:
|  |  | Quarterly Period Ended |  | Two Quarterly Periods Ended
Derivative Instruments | Statements of Income Location |  | March 29, 2025 |  | March 30, 2024 |  | March 29, 2025 |  | March 30, 2024
Cross-currency swaps | Interest expense |  | $ | 3 |  |  | $ | — |  |  | $ | 5 |  |  | $ | — |
Non-recurring Fair Value Measurements The Company has certain assets that are measured at fair value on a non-recurring basis when impairment indicators are present or when the Company completes an acquisition. The Company adjusts certain long-lived assets to fair value only when the carrying values exceed the fair values. The categorization of the framework used to value the assets is considered Level 3, due to the subjective nature of the unobservable inputs used to determine the fair value. These assets that are subject to our impairment analysis primarily include our definite lived and indefinite lived intangible assets, including Goodwill and our Property, plant and equipment. The Company reviews Goodwill and other indefinite lived assets for impairment as of the first day of the fourth fiscal quarter each year and more frequently if impairment indicators exist. As a result of the fiscal 2024 assessment, the Company recorded an impairment charge of $172 million. No impairment indicators were identified in the current quarter. Included in the following tables are the major categories of assets and their current carrying values, along with the impairment loss recognized on the fair value measurement for the period then ended:
| March 29, 2025
| Level 1 |  | Level 2 |  | Level 3 |  | Total |  | Impairment
Indefinite-lived trademarks | $ | — |  |  | $ | — |  |  | $ | 26 |  |  | $ | 26 |  |  | $ | — |
Goodwill | — |  |  | — |  |  | 643 |  |  | 643 |  |  | — |
Definite lived intangible assets | — |  |  | — |  |  | 221 |  |  | 221 |  |  | — |
Property, plant, and equipment | — |  |  | — |  |  | 1,519 |  |  | 1,519 |  |  | — |
Total | $ | — |  |  | $ | — |  |  | $ | 2,409 |  |  | $ | 2,409 |  |  | $ | — |
| September 28, 2024
| Level 1 |  | Level 2 |  | Level 3 |  | Total |  | Impairment
Indefinite-lived trademarks | $ | — |  |  | $ | — |  |  | $ | 26 |  |  | $ | 26 |  |  | $ | — |
Goodwill | — |  |  | — |  |  | 624 |  |  | 624 |  |  | (171) |
Definite lived intangible assets | — |  |  | — |  |  | 200 |  |  | 200 |  |  | (1) |
Property, plant, and equipment | — |  |  | — |  |  | 949 |  |  | 949 |  |  | — |
Total | $ | — |  |  | $ | — |  |  | $ | 1,799 |  |  | $ | 1,799 |  |  | $ | (172) |
The Company’s financial instruments consist primarily of cash and cash equivalents, long-term debt, cross-currency swap agreements, and finance lease obligations. The book value of our marketable long-term indebtedness exceeded fair value by $77 million as of March 29, 2025. The Company’s long-term debt fair values were determined using Level 2 inputs (substantially observable).

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References No definition available. + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration